Solid Biosciences (SLDB) News Today $4.39 -0.07 (-1.57%) (As of 01:02 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Solid Biosciences (NASDAQ:SLDB) Now Covered by Analysts at WedbushDecember 15 at 2:41 AM | americanbankingnews.comSolid Biosciences (NASDAQ:SLDB) Upgraded by Wedbush to Strong-Buy RatingDecember 15 at 1:55 AM | americanbankingnews.comSolid Biosciences (NASDAQ:SLDB) Raised to Strong-Buy at WedbushWedbush upgraded shares of Solid Biosciences to a "strong-buy" rating in a research note on Thursday.December 14, 2024 | marketbeat.comSolid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: AnalystDecember 13, 2024 | benzinga.comWedbush Initiates Coverage of Solid Biosciences (SLDB) with Outperform RecommendationDecember 13, 2024 | msn.comWedbush Begins Coverage on Solid Biosciences (NASDAQ:SLDB)Wedbush assumed coverage on shares of Solid Biosciences in a report on Friday. They set an "outperform" rating and a $16.00 price objective for the company.December 13, 2024 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Raised to "Strong-Buy" at Citizens JmpDecember 13, 2024 | americanbankingnews.comHC Wainwright Reaffirms Buy Rating for Solid Biosciences (NASDAQ:SLDB)HC Wainwright reiterated a "buy" rating and set a $16.00 price objective on shares of Solid Biosciences in a research note on Thursday.December 12, 2024 | marketbeat.comCitizens Jmp Upgrades Solid Biosciences (NASDAQ:SLDB) to "Strong-Buy"Citizens Jmp upgraded Solid Biosciences to a "strong-buy" rating in a report on Tuesday.December 11, 2024 | marketbeat.comBuy Rating Affirmed: Solid Biosciences’ Strong Potential in Gene Therapy for DMD Highlighted by Innovative Technologies and Attractive ValuationDecember 11, 2024 | markets.businessinsider.comJMP Securities Initiates Coverage of Solid Biosciences (SLDB) with Market Outperform RecommendationDecember 11, 2024 | msn.comSolid Biosciences (NASDAQ:SLDB) Now Covered by JMP SecuritiesJMP Securities began coverage on Solid Biosciences in a research report on Tuesday. They set an "outperform" rating and a $15.00 price objective for the company.December 10, 2024 | marketbeat.comPoint72 Asset Management L.P. Acquires 330,234 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Point72 Asset Management L.P. raised its holdings in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 292.8% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 443,010 shares of the company's stock after purchasing anDecember 10, 2024 | marketbeat.comStrategic Collaboration with Mayo Clinic Boosts Solid Biosciences’ Buy Rating for Cardiac Gene Therapy AdvancementsDecember 7, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Solid Biosciences (SLDB), Foghorn Therapeutics (FHTX) and KalVista Pharmaceuticals (KALV)December 6, 2024 | markets.businessinsider.comSolid Biosciences announces collaboration with Mayo ClinicDecember 5, 2024 | markets.businessinsider.comSolid Biosciences Inc. (NASDAQ:SLDB) Insider Jessie Hanrahan Sells 4,610 SharesDecember 5, 2024 | insidertrades.comSolid Biosciences Announces Collaboration with Mayo Clinic to Accelerate Gene Therapy Innovation and Advance Development of Cardiac Gene TherapiesDecember 4, 2024 | markets.businessinsider.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have earned an average recommendation of "Buy" from the nine analysts that are covering the stock, Marketbeat.com reports. Seven investment analysts have rated the stock with a buy rating and two have issued a strong buy rating on tDecember 3, 2024 | marketbeat.comVestal Point Capital LP Has $19.52 Million Stake in Solid Biosciences Inc. (NASDAQ:SLDB)Vestal Point Capital LP raised its stake in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 5.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,800,000 shares of the company's stock after purchasing anNovember 29, 2024 | marketbeat.comSolid Biosciences to Participate at Upcoming Investor ConferencesNovember 26, 2024 | globenewswire.comCantor Fitzgerald Brokers Reduce Earnings Estimates for SLDBSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Stock analysts at Cantor Fitzgerald cut their FY2024 earnings per share estimates for Solid Biosciences in a research report issued to clients and investors on Monday, November 18th. Cantor Fitzgerald analyst C. Duncan now anticipates that theNovember 21, 2024 | marketbeat.comSolid Biosciences Reports Increased Losses Amid R&D FocusNovember 19, 2024 | markets.businessinsider.comWhat is Chardan Capital's Estimate for SLDB FY2024 Earnings?Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at Chardan Capital reduced their FY2024 earnings per share estimates for shares of Solid Biosciences in a report released on Monday, November 11th. Chardan Capital analyst Y. Livshits now anticipates that the company will postNovember 14, 2024 | marketbeat.comSolid Biosciences to Present at the Jefferies London Healthcare ConferenceNovember 14, 2024 | globenewswire.comSolid Biosciences price target lowered to $12 from $15 at JPMorganNovember 13, 2024 | markets.businessinsider.comJPMorgan Chase & Co. Lowers Solid Biosciences (NASDAQ:SLDB) Price Target to $12.00JPMorgan Chase & Co. decreased their target price on shares of Solid Biosciences from $15.00 to $12.00 and set an "overweight" rating for the company in a research report on Tuesday.November 12, 2024 | marketbeat.comSolid Biosciences to participates in a conference call hosted by JPMorganNovember 12, 2024 | markets.businessinsider.comFY2024 EPS Forecast for Solid Biosciences Reduced by AnalystSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Research analysts at HC Wainwright dropped their FY2024 earnings per share estimates for Solid Biosciences in a report issued on Thursday, November 7th. HC Wainwright analyst A. He now anticipates that the company will post earnings per share oNovember 11, 2024 | marketbeat.comFY2024 Earnings Estimate for SLDB Issued By Leerink PartnrsSolid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Equities researchers at Leerink Partnrs dropped their FY2024 earnings per share (EPS) estimates for Solid Biosciences in a research report issued to clients and investors on Wednesday, November 6th. Leerink Partnrs analyst J. Schwartz now anticNovember 11, 2024 | marketbeat.comWhat is William Blair's Estimate for SLDB FY2024 Earnings?Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) - Equities researchers at William Blair reduced their FY2024 earnings per share estimates for shares of Solid Biosciences in a note issued to investors on Wednesday, November 6th. William Blair analyst S. Corwin now expects that the company willNovember 11, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Solid Biosciences (SLDB), Privia Health Group (PRVA) and Jazz Pharmaceuticals (JAZZ)November 9, 2024 | markets.businessinsider.comStrategic Advancements and Optimized Approaches Drive Buy Rating for Solid BiosciencesNovember 9, 2024 | markets.businessinsider.comWe're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn RateNovember 9, 2024 | finance.yahoo.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Average Rating of "Buy" from AnalystsShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given a consensus recommendation of "Buy" by the eight brokerages that are covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating and two have issued a strong buy rating on the cNovember 8, 2024 | marketbeat.comPiper Sandler Reaffirms Their Buy Rating on Solid Biosciences (SLDB)November 7, 2024 | markets.businessinsider.comSolid Biosciences’ Strategic Advances and Clinical Trial Progress Drive Buy RatingNovember 7, 2024 | markets.businessinsider.comSolid Biosciences' (SLDB) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $16.00 price target on shares of Solid Biosciences in a research note on Thursday.November 7, 2024 | marketbeat.comSolid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 6, 2024 | globenewswire.comSolid Biosciences to Participate at the Truist Securities BioPharma SymposiumOctober 31, 2024 | markets.businessinsider.comSolid Biosciences: Buy Rating Reaffirmed Amid Market Skepticism and Upcoming SGT-003 Data ReleaseOctober 26, 2024 | markets.businessinsider.comInsider Selling: Solid Biosciences Inc. (NASDAQ:SLDB) Insider Sells 2,923 Shares of StockOctober 23, 2024 | insidertrades.comSolid Biosciences Inc. (NASDAQ:SLDB) Receives Average Recommendation of "Buy" from AnalystsShares of Solid Biosciences Inc. (NASDAQ:SLDB - Get Free Report) have been given a consensus recommendation of "Buy" by the eight analysts that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and two have given a stOctober 14, 2024 | marketbeat.comSolid Biosciences Inc. (NASDAQ:SLDB) Shares Purchased by Millennium Management LLCMillennium Management LLC boosted its stake in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 135.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,728,065 shares of the company's stock after acquiOctober 9, 2024 | marketbeat.comSolid Biosciences (NASDAQ:SLDB) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comSolid Biosciences (SLDB) Gets a Buy from Piper SandlerOctober 6, 2024 | markets.businessinsider.comMarshall Wace LLP Takes $1.55 Million Position in Solid Biosciences Inc. (NASDAQ:SLDB)Marshall Wace LLP purchased a new position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 274,005 shares of the company's stock, valued at approximately $1,554,000. MaOctober 6, 2024 | marketbeat.com112,776 Shares in Solid Biosciences Inc. (NASDAQ:SLDB) Purchased by Point72 Asset Management L.P.Point72 Asset Management L.P. bought a new stake in shares of Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 112,776 shares of the company's stock, valued at approximately $639,000. Point72 Asset MOctober 5, 2024 | marketbeat.comSolid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)October 2, 2024 | globenewswire.comDeerfield Management Company L.P. Series C Sells 517,000 Shares of Solid Biosciences Inc. (NASDAQ:SLDB)Deerfield Management Company L.P. Series C decreased its position in Solid Biosciences Inc. (NASDAQ:SLDB - Free Report) by 22.9% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,743,398 shares of the company's stock after selling 517,000September 26, 2024 | marketbeat.com Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW SLDB Media Mentions By Week SLDB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLDB News Sentiment▼0.990.55▲Average Medical News Sentiment SLDB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLDB Articles This Week▼112▲SLDB Articles Average Week Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Erasca News Today Cronos Group News Today Evolus News Today Dianthus Therapeutics News Today Rapport Therapeutics News Today Autolus Therapeutics News Today Oculis News Today Cullinan Therapeutics News Today Arbutus Biopharma News Today Entrada Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLDB) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
